New award for bupropion HCL 12HR SA tablets with radha pharmaceuticals INC. Base year ordering period is may 16, 2026 to may 15, 2027 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0012
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Bupropion Tablets 12hr SA Tablets Pre-Solicitation · 36E79725R0065 · Posted Oct 20, 2025
- Last date to order 47% complete
- IDV ceiling
- $8,284,705.50
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Radha Pharmaceuticals Inc. for Bupropion HCL 12-hour Sustained Action Tablets on May 16, 2026, with a ceiling value of $8,284,705.50. The contract is minority-owned and carries no set-aside designation. Place of performance includes supply to the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The originating solicitation (RFP #36E79725R0065) called for unrestricted competition and required offerors to meet strict packaging specifications including safety caps with deshelling capabilities, 120cc minimum bottle volume, cylindrical bottle bodies with specific dimensions, and unique NDC numbers for each labeled product. Estimated annual requirements spanned five tablet configurations in both 60-count safety-cap bottles and 500-count non-safety bottles, with total annual usage ranging from 20,289 to 158,669 bottles depending on dosage and packaging type. The base ordering period runs from May 16, 2026 to May 15, 2027, with four one-year options extending through May 2031. The contract incorporates Section 5 of Executive Order 14398, Clause 52.222-90, addressing discrimination by federal contractors as of April 2026.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0012?
36E79726D0012 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 16, 2026.
How much is contract 36E79726D0012 worth?
36E79726D0012's own ceiling is $8,284,706.
Who can order from contract 36E79726D0012?
36E79726D0012 is a single award indefinite delivery contract.
Was contract 36E79726D0012 competed?
The extent of competition for 36E79726D0012 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV